Profile
Jennifer Laux served as Chief Commercialization Officer at Helius Medical Technologies, Inc. from 2018 to 2019.
Prior to that, she was Vice President-Commercial Development at Inovio Pharmaceuticals, Inc. from 2013 to 2018 and Vice President-Cardiovascular Marketing at Boehringer Ingelheim Corp.
in 2012-2013.
Laux holds a graduate degree from the University of Pennsylvania and an undergraduate degree from Georgetown University.
She also earned an MBA from The Wharton School of the University of Pennsylvania.
Former positions of Jennifer Laux
Companies | Position | End |
---|---|---|
HELIUS MEDICAL TECHNOLOGIES, INC. | Corporate Officer/Principal | 30/08/2019 |
INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2018 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/05/2013 |
Training of Jennifer Laux
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Georgetown University | Undergraduate Degree |
University of Pennsylvania | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
INOVIO PHARMACEUTICALS, INC. | Health Technology |
HELIUS MEDICAL TECHNOLOGIES, INC. | Health Technology |
Private companies | 1 |
---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- Jennifer Laux